CATALYST CAPITAL ADVISORS LLC – Gilead Sciences, Inc. Transaction History
CATALYST CAPITAL ADVISORS LLC portfolio value:
$62,000
portfolio value
CATALYST CAPITAL ADVISORS LLC quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.10% | -1 shares | 0 | $61.69 | 1K |
Q2 2022 | share | Decrease | -71.52% | -2.51K shares | -147K | $61.81 | 1.00K |
Q1 2022 | share | Decrease | -10.31% | -404 shares | -75K | $59.45 | 3.51K |
Q4 2021 | share | Decrease | -1.48% | -59 shares | 6K | $73.36 | 3.91K |
Q3 2021 | share | Decrease | -0.45% | -18 shares | 3K | $69.85 | 3.97K |
Q2 2021 | share | Increase | +437.10% | 3.25K shares | 227K | $68.17 | 3.99K |
Q1 2021 | share | Decrease | -15.74% | -139 shares | -3K | $63.33 | 744 |
Q4 2020 | share | Decrease | -70.57% | -2.11K shares | -139K | $56.43 | 883 |
Q3 2020 | share | Decrease | -33.33% | -1.5K shares | -156K | $60.52 | 3K |
Q2 2020 | share | Decrease | -67.63% | -9.4K shares | -693K | $72.94 | 4.5K |
Q1 2020 | share | Increase | 0.00% | 13.9K shares | 1.03M | $70.22 | 13.9K |
Q2 2018 | share | Decrease | -100.00% | -50.51K shares | -3.80M | $62.43 | 0 |
Q1 2018 | share | Increase | +6.68% | 3.16K shares | 416K | $65.91 | 50.51K |
Q4 2017 | share | Decrease | -2.68% | -1.30K shares | -550K | $62.19 | 47.34K |
Q3 2017 | share | Decrease | -14.20% | -8.05K shares | -72K | $69.84 | 48.65K |
Q2 2017 | share | Increase | +6.45% | 3.43K shares | 396K | $60.63 | 56.70K |
Q1 2017 | share | Increase | +10.59% | 5.10K shares | 169K | $57.72 | 53.27K |
Q4 2016 | share | Increase | +2.73% | 1.28K shares | -261K | $60.39 | 48.16K |
Q3 2016 | share | Decrease | -0.38% | -177 shares | -216K | $66.31 | 46.88K |
Q2 2016 | share | Decrease | -66.99% | -95.50K shares | -9.17M | $69.49 | 47.06K |
Q1 2016 | share | Decrease | -4.62% | -6.9K shares | -2.02M | $76.1 | 142.56K |